Monneret G et al. |
15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. |
2002 |
J. Immunol. |
pmid:11907120
|
Maier NK et al. |
The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes. |
2015 |
J. Immunol. |
pmid:25681332
|
Zhang X et al. |
Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2. |
2001 |
J. Immunol. |
pmid:11390455
|
Parsons WG and Roberts LJ |
Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. |
1988 |
J. Immunol. |
pmid:3139758
|
Mandal AK et al. |
Yin-yang: balancing act of prostaglandins with opposing functions to regulate inflammation. |
2005 |
J. Immunol. |
pmid:16272277
|
Xue L et al. |
Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. |
2005 |
J. Immunol. |
pmid:16272307
|
Sarashina H et al. |
Opposing immunomodulatory roles of prostaglandin D2 during the progression of skin inflammation. |
2014 |
J. Immunol. |
pmid:24298012
|
Levi-Schaffer F et al. |
Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. |
1985 |
J. Immunol. |
pmid:2413121
|
Ogasawara T et al. |
Mouse bone marrow-derived mast cells undergo exocytosis, prostanoid generation, and cytokine expression in response to G protein-activating polybasic compounds after coculture with fibroblasts in the presence of c-kit ligand. |
1997 |
J. Immunol. |
pmid:8977215
|
Tanaka K et al. |
Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. |
2000 |
J. Immunol. |
pmid:10679060
|
Chevalier E et al. |
Cutting edge: chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil recruitment. |
2005 |
J. Immunol. |
pmid:16081770
|
Fox CC et al. |
Isolation and characterization of human intestinal mucosal mast cells. |
1985 |
J. Immunol. |
pmid:2582045
|
Urade Y et al. |
The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. |
1989 |
J. Immunol. |
pmid:2509561
|
Equils O et al. |
Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. |
2001 |
J. Immunol. |
pmid:11160291
|
Rocklin RE et al. |
Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2). |
1985 |
J. Immunol. |
pmid:3160784
|
Mizutani N et al. |
Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. |
2007 |
J. Immunol. |
pmid:18025192
|
Hu ZQ et al. |
An essential role of prostaglandin E on mouse mast cell induction. |
1995 |
J. Immunol. |
pmid:7636261
|
Gosset P et al. |
Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. |
2003 |
J. Immunol. |
pmid:12734337
|
Schulman ES et al. |
Heterogeneity of human mast cells. |
1983 |
J. Immunol. |
pmid:6194221
|
Schlezinger JJ et al. |
Environmental and endogenous peroxisome proliferator-activated receptor gamma agonists induce bone marrow B cell growth arrest and apoptosis: interactions between mono(2-ethylhexyl)phthalate, 9-cis-retinoic acid, and 15-deoxy-Delta12,14-prostaglandin J2. |
2004 |
J. Immunol. |
pmid:15322177
|
Si Q et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications. |
2004 |
J. Immunol. |
pmid:15322215
|
Nomiya R et al. |
CRTH2 plays an essential role in the pathophysiology of Cry j 1-induced pollinosis in mice. |
2008 |
J. Immunol. |
pmid:18390753
|
Schulman ES et al. |
Histochemical heterogeneity of dispersed human lung mast cells. |
1990 |
J. Immunol. |
pmid:1692857
|
Menè P |
Prostaglandin D2 : a Cinderella of vascular cell biology? |
2002 |
J. Hypertens. |
pmid:12131515
|
Negoro H et al. |
Endogenous prostaglandin D2 synthesis reduces an increase in plasminogen activator inhibitor-1 following interleukin stimulation in bovine endothelial cells. |
2002 |
J. Hypertens. |
pmid:12131531
|
Han XQ et al. |
Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response. |
2014 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:24496672
|
Zhang M et al. |
Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis. |
2003 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:12973930
|
López-Parra M et al. |
The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARgamma. Influence of albumin. |
2005 |
J. Hepatol. |
pmid:15629510
|
Tran-Thi TA et al. |
Net prostaglandin release by perfused rat liver after stimulation with phorbol 12-myristate 13-acetate. |
1988 |
J. Hepatol. |
pmid:3166024
|
Hoffmann R et al. |
Regulation of interleukin-6 receptor expression in rat Kupffer cells: modulation by cytokines, dexamethasone and prostaglandin E2. |
1994 |
J. Hepatol. |
pmid:7814800
|
Gressner OA et al. |
Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. |
2008 |
J. Hepatol. |
pmid:18486259
|
Li L et al. |
Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. |
2004 |
J. Hepatol. |
pmid:15336443
|
Tran-Thi TA et al. |
Effects of hypoxia on the oxygen-dependent metabolism of prostaglandins and adenosine in liver cells. |
1994 |
J. Hepatol. |
pmid:8071531
|
Tran-Thi TA et al. |
Studies on synthesis and degradation of eicosanoids by rat hepatocytes in primary culture. |
1987 |
J. Hepatol. |
pmid:2828463
|
Santoro MG et al. |
PGJ2, a new antiviral prostaglandin: inhibition of Sendai virus replication and alteration of virus protein synthesis. |
1987 |
J. Gen. Virol. |
pmid:3033130
|
Rollins MD et al. |
Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. |
2006 Sep-Oct |
J. Gastrointest. Surg. |
pmid:16966031
|
Yamamoto Y et al. |
Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats. |
2008 |
J. Gastroenterol. Hepatol. |
pmid:18565023
|
Berruyer C et al. |
Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. |
2006 |
J. Exp. Med. |
pmid:17145956
|
Mellor EA et al. |
Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. |
2002 |
J. Exp. Med. |
pmid:11877481
|
Honda K et al. |
Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. |
2003 |
J. Exp. Med. |
pmid:12925672
|
Murakami M et al. |
The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through posttranslational activation of cytosolic phospholipase A2 and 5-lipoxygenase. |
1995 |
J. Exp. Med. |
pmid:7540649
|
Chilton FH et al. |
Antigen-induced generation of lyso-phospholipids in human airways. |
1996 |
J. Exp. Med. |
pmid:8642333
|
Angeli V et al. |
Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. |
2001 |
J. Exp. Med. |
pmid:11369785
|
Hirai H et al. |
Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. |
2001 |
J. Exp. Med. |
pmid:11208866
|
Hammad H et al. |
Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. |
2007 |
J. Exp. Med. |
pmid:17283205
|
Kilunga Kubata B et al. |
Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in humans. |
1998 |
J. Exp. Med. |
pmid:9743538
|
Kubata BK et al. |
Identification of a novel prostaglandin f(2alpha) synthase in Trypanosoma brucei. |
2000 |
J. Exp. Med. |
pmid:11067881
|
Kubata BK et al. |
A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. |
2002 |
J. Exp. Med. |
pmid:12417633
|
Hsieh FH et al. |
T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. |
2001 |
J. Exp. Med. |
pmid:11136826
|
Kong D et al. |
PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation. |
2016 |
J. Exp. Med. |
pmid:27621415
|
Tasaka K et al. |
Prostaglandin D2 induces release of luteinizing hormone from the rat pituitary gland without the modulation of hypothalamic luteinizing hormone releasing hormone. |
1983 |
J. Endocrinol. |
pmid:6361197
|
Kurtz M et al. |
Peroxisome proliferator-activated receptor ligands regulate lipid content, metabolism, and composition in fetal lungs of diabetic rats. |
2014 |
J. Endocrinol. |
pmid:24389592
|
Knepel W et al. |
Inhibition by prostaglandin E2 of the release of vasopressin and beta-endorphin from rat pituitary neurointermediate lobe or medial basal hypothalamus in vitro. |
1985 |
J. Endocrinol. |
pmid:3160802
|
Löhrke B et al. |
Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. |
1998 |
J. Endocrinol. |
pmid:9834460
|
Takano H and Komuro I |
Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease. |
2002 Jan-Feb |
J. Diabetes Complicat. |
pmid:11872377
|
Goya K et al. |
The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells. |
2006 Sep-Oct |
J. Diabetes Complicat. |
pmid:16949522
|
Soifer SJ et al. |
The developmental effects of prostaglandin D2 on the pulmonary and systemic circulations in the newborn lamb. |
1983 |
J. Dev. Physiol. |
pmid:6579103
|
Hau CS et al. |
Suppressive effects of antimycotics on thymic stromal lymphopoietin production in human keratinocytes. |
2013 |
J. Dermatol. Sci. |
pmid:23688403
|
Pierron A et al. |
PGJ2 restores RA sensitivity in melanoma cells by decreasing PRAME and EZH2. |
2014 |
J. Dermatol. Sci. |
pmid:24289988
|
Amon U et al. |
Investigations on plasma levels of mast cell mediators in acute atopic dermatitis. |
1994 |
J. Dermatol. Sci. |
pmid:8193085
|
Schütz TC et al. |
Effects of COX-2 inhibitor in temporomandibular joint acute inflammation. |
2007 |
J. Dent. Res. |
pmid:17452571
|
Fukuchi K et al. |
Apoptosis in human oral squamous cell carcinomas is induced by 15-deoxy-delta 12,14-prostaglandin J2 but not by troglitazone. |
2003 |
J. Dent. Res. |
pmid:14514760
|
Lutzow YS et al. |
15-Deoxy-Delta12,14-prostaglandin J2 induces chemokine expression, oxidative stress and microfilament reorganization in bovine mammary epithelial cells. |
2008 |
J. Dairy Res. |
pmid:18226310
|
Kunkel SL et al. |
Suppression of immune complex vasculitis in rats by prostaglandin. |
1979 |
J. Clin. Invest. |
pmid:159314
|
Rozera C et al. |
Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block. |
1996 |
J. Clin. Invest. |
pmid:8621762
|
Benyó Z et al. |
GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. |
2005 |
J. Clin. Invest. |
pmid:16322797
|
Zhao J et al. |
Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. |
2011 |
J. Clin. Invest. |
pmid:22105170
|
Braciale TJ and Kim TS |
Slowing down with age: lung DCs do it too. |
2011 |
J. Clin. Invest. |
pmid:22105176
|
Weinreich D and Undem BJ |
Immunological regulation of synaptic transmission in isolated guinea pig autonomic ganglia. |
1987 |
J. Clin. Invest. |
pmid:2437156
|
Adler DH et al. |
Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. |
2008 |
J. Clin. Invest. |
pmid:18451993
|
Kawahito Y et al. |
15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. |
2000 |
J. Clin. Invest. |
pmid:10903334
|
Togias AG et al. |
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. |
1985 |
J. Clin. Invest. |
pmid:2414318
|
Creticos PS et al. |
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. |
1985 |
J. Clin. Invest. |
pmid:2416777
|
Adams M et al. |
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. |
1997 |
J. Clin. Invest. |
pmid:9399962
|
Passeron T et al. |
Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. |
2009 |
J. Clin. Invest. |
pmid:19273910
|
Charlesworth EN et al. |
Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. |
1989 |
J. Clin. Invest. |
pmid:2468688
|
Schulman ES et al. |
Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. |
1988 |
J. Clin. Invest. |
pmid:2449462
|
Pipkorn U et al. |
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. |
1987 |
J. Clin. Invest. |
pmid:2443539
|
Schleimer RP et al. |
Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. |
1983 |
J. Clin. Invest. |
pmid:6134755
|
Powell WS |
15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product? |
2003 |
J. Clin. Invest. |
pmid:12975467
|
Bell-Parikh LC et al. |
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. |
2003 |
J. Clin. Invest. |
pmid:12975479
|
Tokudome S et al. |
Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. |
2009 |
J. Clin. Invest. |
pmid:19451694
|
Su CG et al. |
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. |
1999 |
J. Clin. Invest. |
pmid:10449430
|
Beasley CR et al. |
9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways. |
1987 |
J. Clin. Invest. |
pmid:3469218
|
Song WL et al. |
Niacin and biosynthesis of PGDâ‚‚by platelet COX-1 in mice and humans. |
2012 |
J. Clin. Invest. |
pmid:22406532
|
Chearwae W and Bright JJ |
15-deoxy-Delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte. |
2008 |
J. Clin. Immunol. |
pmid:18463970
|
Kawano S et al. |
Protective effect of PGD2 against ethanol-induced gastric mucosal injury in rats. |
1990 |
J. Clin. Gastroenterol. |
pmid:2212542
|
Kasim-Karakas SE et al. |
Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. |
2004 |
J. Clin. Endocrinol. Metab. |
pmid:14764771
|
Mitchell MD et al. |
Identification of 9alpha,11beta-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues. |
2005 |
J. Clin. Endocrinol. Metab. |
pmid:15840748
|
Schaiff WT et al. |
Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner. |
2000 |
J. Clin. Endocrinol. Metab. |
pmid:11061552
|
Helliwell RJ et al. |
Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta. |
2006 |
J. Clin. Endocrinol. Metab. |
pmid:16291703
|
Lappas M et al. |
Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:12364456
|
Carr BR et al. |
Prostaglandin secretion by the neocortex and fetal zones of the human fetal adrenal gland. |
1983 |
J. Clin. Endocrinol. Metab. |
pmid:6313732
|
Lindström TM and Bennett PR |
15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications. |
2005 |
J. Clin. Endocrinol. Metab. |
pmid:15755849
|
Schwartz MS et al. |
Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a phase I metabolite. |
2006 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:16716772
|
Schmidt R et al. |
LC-MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of rats. |
2005 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:16172029
|
Morrow JD and Minton TA |
Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry. |
1993 |
J. Chromatogr. |
pmid:8468374
|
Chiabrando C et al. |
Quantitative profiling of prostaglandins and thromboxane by high-resolution gas chromatography-selected--ion monitoring. |
1983 |
J. Chromatogr. |
pmid:6584432
|
Zhao X et al. |
15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. |
2006 |
J. Cereb. Blood Flow Metab. |
pmid:16208315
|
Pereira MP et al. |
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. |
2006 |
J. Cereb. Blood Flow Metab. |
pmid:16034372
|